We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 766

ACI biosimilars 2015 features new discussions on Zarxio and patent dance (mis-)steps
  • McGuireWoods LLP
  • USA
  • June 3 2015

On June 1-2, the American Conference Institute (ACI) held its 6th Annual Summit on Biosimilars to its largest crowd ever, over 150 participants. New


FDA flexes muscles over dietary supplements
  • McGuireWoods LLP
  • USA
  • May 5 2015

In a move designed to halt sales of popular workout stimulants, the U.S. Food and Drug Administration (FDA) recently issued warning letters to some 14


Will increased consolidation in the insurance industry yield opportunities or challenges for investors?
  • McGuireWoods LLP
  • USA
  • June 23 2015

A recent flurry of activity in the health insurance industry would seem to indicate that investors can expect significant consolidation in the


PHOs banned in the U.S.: landmark FDA order declares partially hydrogenated oils no longer GRAS
  • McGuireWoods LLP
  • USA
  • June 17 2015

On June 17, 2015, FDA issued its much-anticipated Final Determination Regarding Partially Hydrogenated Oils (Order), finding there is “no longer a


DIA 2015 provides panels on all types of FDA-regulated products with many opportunities for insight and interaction part two of two
  • McGuireWoods LLP
  • USA
  • June 19 2015

This is the second part of coverage of the Drug Information Association (DIA)' 51st Annual Meeting, held on June 15-18, 2015 in Washington, D.C. For


Weekly Washington healthcare update
  • McGuireWoods LLP
  • USA
  • June 3 2013

On May 28, the Energy and Commerce Committee released a third draft of a proposal to overhaul Medicare's physician payment system. The panel has


DIA 2015 provides panels on all types of FDA-regulated products with many opportunities for insight and interaction part one of two
  • McGuireWoods LLP
  • USA
  • June 18 2015

On June 15-18, 2015 the Drug Information Association (DIA) held its 51st Annual Meeting in Washington, D.C. This is the largest multidisciplinary


Actavis loses Nameda appeal over “hot documents”
  • McGuireWoods LLP
  • USA
  • May 29 2015

The U.S. Court of Appeals for the Second Circuit's opinion (issued May 22, 2015 with a public, redacted version available May 28, 2015), affirming


Late to the party: EEOC proposes wellness program regulations - McguireWoods healthcare reform guide: installment No. 50
  • McGuireWoods LLP
  • USA
  • May 28 2015

This is the 50th in a series of WorkCite articles concerning the Patient Protection and Affordable Care Act and its companion statute, the Health


Weekly Washington healthcare update - June 22, 2015
  • McGuireWoods LLP
  • USA
  • June 22 2015

Leading Up to the SCOTUS King v. Burwell Decision... House Votes to Repeal the Medical Device Tax... CMS Announces It Will Bolster Transitional